Major Health Systems to Collaborate on Gun Violence Solutions yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Published: Apr 07, 2021
- Program Powered by Applied DNA’s Mutation-targeted qPCR Assays and NGS Platform -
- Program Data Potentially Relevant to COVID-19 Vaccine and Therapeutics Developers, Precision Medicine -
STONY BROOK & NEW HYDE PARK, N.Y. (BUSINESS WIRE) Applied DNA Sciences, Inc.. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and Northwell Health (Northwell) today announced their entry into a
pro bono Material Transfer Agreement (MTA) that establishes a real-time surveillance program for the tracking and identification of SARS-CoV-2 mutations and variants of concern (VoCs) in Northwell’s COVID-positive specimens (the “Program”). Under the Program, de-identified positive COVID-19 specimens supplied by Northwell are being screened for SARS-CoV-2 mutations found in currently known VoCs using Applied DNA’s Linea
Colorectal cancer is on the rise among people under 50: patch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from patch.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
AUSTIN, Texas, Feb. 23, 2021 /PRNewswire/ Oracle today announced that Northwell Health, one of the largest health systems in New York, turned to Oracle Analytics Cloud, built on the highly secure, scalable Oracle Cloud Infrastructure, and Oracle Autonomous Data Warehouse to optimize patient care during the COVID-19 pandemic. With Oracle, Northwell Health is able to monitor available nursing resources, predict upcoming staffing needs and accommodate a continually shifting patient load.
Northwell Health operates 23 hospitals with a combined 74,000 employees across New York and treats millions of patients annually. In the fight against COVID-19, every minute counts and having quick access to astronomical amounts of data combined with powerful analytics to enable visibility into rapidly changing patient loads and staffing requirements has given Northwell Health the necessary speed to optimize patient care. In order to not be overburdened with a
Northwell Health and Cold Spring Harbor Laboratory open virtual COVID-19 clinical trial for non-hospitalized patients
By
Staff
2 months ago
An outpatient, digital, randomized clinical trial will look at the safety and efficacy of famotidine (PEPCID) to treat mild to moderate Covid-19
MANHASSET, N.Y.–(BUSINESS WIRE)–The Feinstein Institutes for Medical Research and Cold Spring Harbor Laboratory (CSHL) are recruiting patients in a fully virtual, in-home, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of famotidine, or PEPCID, for the outpatient treatment of the novel coronavirus disease 2019 (COVID-19) in adults. Sold over-the-counter as PEPCID, famotidine is a histamine 2 blocker used to decrease stomach acid and this clinical trial will assess its use as a COVID-19 therapy.